13F-HR filed by Altium Capital Management LLC
Altium Capital Management LLC filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 94 holding rows worth $196,777,806.
- Accession
- 0001420506-23-000571
- Filer
- CIK 1746382
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 94 entries on the cover page, a total value of $196,777,806 stated on the cover page (in dollars after the unit check, H1), rows summing to $196,777,806 with VALUE read as dollars as filed, 13F file number 028-20820. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 1,355,372 | $20,181,489 | dollars as filed | |
| ADMA BIOLOGICS INC | 000899104 | COM | 2,870,000 | $11,135,600 | dollars as filed | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 385,000 | $10,087,000 | dollars as filed | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 1,132,000 | $9,305,040 | dollars as filed | |
| PEPPERLIME HEALTH ACQUSTN CO | G70021103 | COM | 735,000 | $7,504,350 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 125,000 | $6,850,000 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 1,025,000 | $6,426,750 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 215,000 | $5,617,950 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 100,000 | $5,292,000 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 140,000 | $5,173,000 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 170,000 | $4,950,400 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 150,000 | $4,647,000 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 160,000 | $4,352,000 | dollars as filed | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 22,000 | $4,323,000 | dollars as filed | |
| XTANT MED HLDGS INC | 98420P308 | COM NEW | 6,246,291 | $4,122,552 | dollars as filed | |
| IVERIC BIO INC | 46583P102 | COM | 190,000 | $4,067,900 | dollars as filed | |
| TANDEM DIABETES CARE INC | 875372203 | COM NEW | 90,000 | $4,045,500 | dollars as filed | |
| GLAUKOS CORP COM | 377322102 | Stock | 91,000 | $3,974,880 | dollars as filed | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 620,000 | $3,862,600 | dollars as filed | |
| OUTLOOK THERAPEUTICS INC | 69012T206 | COM | 3,327,404 | $3,593,596 | dollars as filed | |
| RESMED INC COM | 761152107 | Stock | 17,000 | $3,538,210 | dollars as filed | |
| AKOYA BIOSCIENCES INC COM | 00974H104 | Stock | 330,000 | $3,158,100 | dollars as filed | |
| QUANTERIX CORP | 74766Q101 | COMMON STOCK | 224,800 | $3,113,480 | dollars as filed | |
| MYRIAD GENETICS INC | 62855J104 | COM | 212,000 | $3,076,120 | dollars as filed | |
| KORU MEDICAL SYSTEMS INC | 759910102 | COMMON STOCK | 855,000 | $3,052,350 | dollars as filed | |
| NEVRO CORP | 64157F103 | COM | 76,000 | $3,009,600 | dollars as filed | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 365,000 | $2,985,700 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 200,000 | $2,776,000 | dollars as filed | |
| CTI BIOPHARMA CORP | 12648L601 | COM | 450,000 | $2,704,500 | dollars as filed | |
| SI BONE INC | 825704109 | COM | 195,000 | $2,652,000 | dollars as filed | |
| NEOGENOMICS INC | 64049M209 | COM NEW | 285,000 | $2,633,400 | dollars as filed | |
| CARA THERAPEUTICS INC | 140755109 | COM | 195,960 | $2,104,610 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 17,500 | $2,090,200 | dollars as filed | |
| COLLEGIUM PHARMACEUTICAL INC | 19459J104 | COM | 90,000 | $2,088,000 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 43,000 | $2,061,850 | dollars as filed | |
| TG VENTURE ACQUISITION CORP | 87251T208 | UNIT 08/15/2028 | 200,000 | $2,038,000 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 100,000 | $1,933,000 | dollars as filed | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 50,000 | $1,907,000 | dollars as filed | |
| NULL | 09071M205 | NULL | 3,103,635 | $1,831,145 | dollars as filed | |
| AULT DISRUPTIVE TECHS CORP | 05150A104 | COM | 150,000 | $1,537,500 | dollars as filed | |
| TG THERAPEUTICS INC | 88322Q908 | COM | 100,000 | $1,183,000 | dollars as filed | call |
| SYROS PHARMACEUTICALS INC | 87184Q206 | COM NEW | 315,070 | $1,131,101 | dollars as filed | |
| WESTERN ACQSTN VENTURES CORP | 95758L206 | UNIT 09/01/2026 | 100,000 | $1,100,000 | dollars as filed | |
| MURPHY CANYON ACQUISITION CO | 626642201 | UNIT 01/25/2027 | 100,000 | $1,018,000 | dollars as filed | |
| ARYA SCIENCES ACQU CORP IV | G31659108 | COM | 100,000 | $1,010,000 | dollars as filed | |
| COLISEUM ACQUISITION CORP | G2263T123 | COM | 85,000 | $853,400 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 359,051 | $811,455 | dollars as filed | |
| SOMALOGIC INC | 83444K105 | COM | 310,000 | $778,100 | dollars as filed | |
| HYRECAR INC | 44916T107 | COM | 1,688,120 | $715,763 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 70,000 | $712,600 | dollars as filed | |
| FAT BRANDS INC | 30258N121 | *W EXP 07/16/202 | 227,000 | $683,270 | dollars as filed | |
| RXSIGHT INC | 78349D107 | COM | 50,586 | $640,925 | dollars as filed | |
| POLISHED COM INC | 28252C109 | CMN | 1,000,821 | $578,174 | dollars as filed | |
| PEPGEN INC COM | 713317105 | Stock | 40,000 | $534,800 | dollars as filed | |
| GSR II METEORA ACQUISITN COR | 36263W204 | UNIT 02/24/2027 | 50,000 | $528,500 | dollars as filed | |
| DOUBLEDOWN INTERACTIVE CO LT | 25862B109 | ADS | 60,876 | $514,402 | dollars as filed | |
| OPY ACQUISITION CORP I | 671005106 | COM | 50,000 | $501,000 | dollars as filed | |
| COLOMBIER ACQUISITION CORP | 19533H108 | COM | 50,000 | $497,000 | dollars as filed | |
| POLISHED COM INC | 28252C117 | *W EXP 06/02/202 | 6,103,824 | $488,306 | dollars as filed | |
| MEDIWOUND LTD | M68830112 | COMMON STOCK | 27,286 | $368,088 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 28,198 | $349,937 | dollars as filed | |
| ABEONA THERAPEUTICS INC | 00289Y206 | COM NEW | 108,696 | $334,784 | dollars as filed | |
| TROIKA MEDIA GROUP INC | 89689F305 | COM | 2,672,640 | $310,026 | dollars as filed | |
| LIGHTNING EMOTORS INC | 53228T101 | COM | 581,852 | $213,249 | dollars as filed | |
| WEARABLE DEVICES LTD | M97838110 | *W EXP 09/14/202 | 1,411,600 | $171,086 | dollars as filed | |
| DIRECT DIGITAL HOLDINGS INC | 25461T113 | *W EXP 02/15/202 | 180,000 | $140,400 | dollars as filed | |
| ASTRIA THERAPEUTICS INC | 04635X902 | COM | 7,700 | $114,653 | dollars as filed | call |
| HEALTH SCIENCES ACQ CORP 2 | G4411D109 | ORD SHS | 10,000 | $99,800 | dollars as filed | |
| NEXERA TECHNOLOGIES LTD | M61472110 | *W EXP 08/26/202 | 480,770 | $79,327 | dollars as filed | |
| Cingulate Inc W Exp 12/10/202 | 17248W113 | Warrant | 270,000 | $64,827 | dollars as filed | |
| ONFOLIO HOLDINGS INC | 68277K124 | *W EXP 01/02/202 | 200,000 | $48,000 | dollars as filed | |
| HARBOR CUSTOM DEVELOPMENT IN | 41150T124 | *W EXP 10/07/202 | 650,000 | $38,935 | dollars as filed | |
| NOCTURNE ACQUISITION CORP | G6580S106 | RIGHT 12/26/2025 | 500,000 | $38,900 | dollars as filed | |
| NLS PHARMACEUTICS LTD | H57830111 | *W EXP 02/02/202 | 200,000 | $38,010 | dollars as filed | |
| NEXGEL INC | 65344E115 | *W EXP 12/27/202 | 225,000 | $33,750 | dollars as filed | |
| LIGHTNING EMOTORS INC 11.5000EXP05/18/2025 | 53228T119 | WARR | 652,173 | $25,304 | dollars as filed | |
| PEPPERLIME HEALTH ACQUSTN CO | G70021111 | *W EXP 10/01/202 | 367,500 | $24,071 | dollars as filed | |
| CEA INDUSTRIES INC | 86887P119 | *W EXP 02/11/202 | 250,000 | $22,500 | dollars as filed | |
| CHAVANT CAPITAL ACQUISITN CO | G2058L111 | *W EXP 99/99/999 | 150,000 | $21,705 | dollars as filed | |
| NEXALIN TECHNOLOGY INC | 65345B110 | *W EXP 99/99/999 | 105,000 | $21,000 | dollars as filed | |
| TILRAY BRANDS INC | 88688T900 | Option | 7,600 | $20,444 | dollars as filed | call |
| BRUUSH ORAL CARE INC | 11750K120 | *W EXP 08/03/202 | 360,579 | $19,543 | dollars as filed | |
| INNOVATIVE EYEWEAR INC | 45791D117 | *W EXP 08/16/202 | 150,000 | $18,345 | dollars as filed | |
| HARBOR CUSTOM DEVELOPMENT IN | 41150T116 | *W EXP 05/09/202 | 600,000 | $17,400 | dollars as filed | |
| DIGITAL HEALTH ACQUISITION C | 253893119 | *W EXP 99/99/999 | 150,000 | $14,835 | dollars as filed | |
| PROSOMNUS INC | 50535E116 | *W EXP 04/20/202 | 150,000 | $11,790 | dollars as filed | |
| BOA ACQUISITION CORP | g8059b119 | WT | 101,439 | $8,115 | dollars as filed | |
| EUCRATES BIOMEDICAL ACQU COR | G3141W122 | *W EXP 10/23/202 | 133,333 | $7,413 | dollars as filed | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 82,233 | $7,023 | dollars as filed | |
| OPY ACQUISITION CORP I | 671005114 | *W EXP 09/22/202 | 50,000 | $3,225 | dollars as filed | |
| Relativity Acquisition Corp | 75944B114 | Warrant | 100,000 | $3,010 | dollars as filed | |
| COLISEUM ACQUISITION CORP | G2263T107 | *W EXP 08/22/202 | 28,333 | $2,026 | dollars as filed | |
| TC BIOPHARM HOLDINGS PLC | 87807D111 | *W EXP 02/10/202 | 18,823 | $1,684 | dollars as filed | |
| COLOMBIER ACQUISITION CORP | 19533H116 | *W EXP 99/99/999 | 16,666 | $1,433 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-23-000571 | this filing | 2023-02-14 | acceptance time not in the bulk data set |